Kenvue (NYSE:KVUE) reported third quarter results that were in line with analysts' expectations.
For the full year, the company forecasts adjusted earnings per share of $1.26 to $1.28, also in line with expectations. Organic revenue is seen rising 5.5-6.0%, while analysts were looking for growth of 5.9%.
For Q3, the adjusted EPS of 31 cents was just a tad worse than the consensus of 32 cents. Revenue of $3.92 billion came in line with estimates.
“We continued to execute on our commitment to delivering sustainable and profitable growth this quarter. Our operating results and strong cash generation underscore the strength of our leadership position in consumer health, and reflect the strong foundation of the company we are building with durable advantage over the long-term,” said Thibaut Mongon, Chief Executive Officer and Director.